Page 8 - Dane Andreeff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Helius Medical Technologies (NASDAQ:HSDT – Get Rating) posted its quarterly earnings data on Monday. The company reported ($1.31) EPS for the quarter, missing the Zacks’ consensus estimate of ($1.16) by ($0.15), MarketWatch Earnings reports. Helius Medical Technologies had a negative net margin of 3,640.44% and a negative return on equity of 227.11%. Helius Medical Technologies […]

NEWTOWN, Pa., March 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused...

-- Fourth Quarter 2021 Revenue Projected to Range from $250,000 to $260,000 -- -- Unaudited Year End Cash Balance of $11 million -- -- Continued...

Helius Medical Technologies Inc announces that the United States Patent and Trademark Office has issued US Patent No. 11,197,994, which is directed to systems for providing non-invasive neurorehabilitation of a patient.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.